High-Density Lipoprotein Changes in Alzheimer’s Disease Are APOE Genotype-Specific

High-density lipoproteins (HDL) play a critical role in cholesterol homeostasis. Apolipoprotein E (APOE), particularly the E4 allele, is a significant risk factor for Alzheimer’s disease but is also a key HDL-associated protein involved in lipid transport in both the periphery and central nervous systems. The objective was to determine the influence of the APOE genotype on HDL function and size in the context of Alzheimer’s disease. HDL from 194 participants (non-demented controls, mild cognitive impairment, and Alzheimer’s disease dementia) were isolated from the plasma. The HDL cholesterol efflux capacity (CEC), lecithin-cholesterol acyltransferase (LCAT) activity, and particle diameter were measured. Neuropsychological test scores, clinical dementia rating, and magnetic resonance imaging scores were used to determine if cognition is associated with HDL function and size. HDL CEC and LCAT activity were reduced in APOE3E4 carriers compared to APOE3E3 carriers, regardless of diagnosis. In APOE3E3 carriers, CEC and LCAT activity were lower in patients. In APOE3E4 patients, the average particle size was lower. HDL LCAT activity and particle size were positively correlated with the neuropsychological scores and negatively correlated with the clinical dementia rating. We provide evidence for the first time of APOE genotype-specific alterations in HDL particles in Alzheimer’s disease and an association between HDL function, size, and cognitive function.

[1]  L. Schneider,et al.  The small HDL particle hypothesis of Alzheimer’s disease , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  Jea Woo Kang,et al.  Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) Cholesterol Efflux Capacity and Is Associated with Changes in the HDL Glycoproteome in Children , 2021, ACS omega.

[3]  H. Yassine,et al.  Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases , 2021, Frontiers in Physiology.

[4]  Jea Woo Kang,et al.  Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins , 2021, Scientific Reports.

[5]  P. Sachdev,et al.  Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes , 2021, Translational Psychiatry.

[6]  C. Cervellati,et al.  Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis , 2021, Diagnostics.

[7]  N. Rotllan,et al.  Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia , 2021, Current Atherosclerosis Reports.

[8]  Anonymous,et al.  2021 Alzheimer's disease facts and figures , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[9]  K. Shimada,et al.  The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation , 2021, Scientific Reports.

[10]  D. Galimberti,et al.  ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease[S] , 2019, Journal of Lipid Research.

[11]  C. Wellington,et al.  HDL from an Alzheimer's disease perspective , 2019, Current opinion in lipidology.

[12]  M. Mimura,et al.  The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up , 2019, Translational Psychiatry.

[13]  A. Tall,et al.  Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[14]  S. Kashyap,et al.  Glycation Reduces the Stability of ApoAI and Increases HDL Dysfunction in Diet-Controlled Type 2 Diabetes , 2018, The Journal of clinical endocrinology and metabolism.

[15]  Anna Gluba-Brzózka,et al.  The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk , 2017, Lipids in Health and Disease.

[16]  Olga V. Demler,et al.  Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) , 2017, Circulation.

[17]  D. Harvey,et al.  Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort , 2017, Alzheimer's & Dementia.

[18]  K. Kotani,et al.  The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[19]  H. Chui,et al.  ABCA1‐Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease , 2016, Journal of the American Heart Association.

[20]  D. Harvey,et al.  Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. , 2015, JAMA neurology.

[21]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[22]  Michael Holzer,et al.  Aging affects high-density lipoprotein composition and function , 2013, Biochimica et biophysica acta.

[23]  D. Rader,et al.  The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? , 2012, Nature Medicine.

[24]  S. Hama,et al.  HDL functionality , 2012, Current opinion in lipidology.

[25]  A. Cardona,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[26]  G. Pawelec,et al.  Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease , 2012, Mechanisms of Ageing and Development.

[27]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[28]  P. Visser,et al.  Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[30]  M. Linton,et al.  Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[31]  C. DeCarli,et al.  Recruitment of a Community-based Cohort for Research on Diversity and Risk of Dementia , 2010, Alzheimer disease and associated disorders.

[32]  A. Smith,et al.  Predicting the time of conversion to MCI in the elderly , 2009, Neurology.

[33]  A. Kontush,et al.  Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[34]  N. Brot,et al.  Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I , 2008, Proceedings of the National Academy of Sciences.

[35]  G. Kaysen Metabolic syndrome and renal failure: similarities and differences. , 2006, Panminerva Medica (Testo stampato).

[36]  Paul K Crane,et al.  Spanish and English Neuropsychological Assessment Scales (SENAS): further development and psychometric characteristics. , 2004, Psychological assessment.

[37]  D. Zaitchik,et al.  Predicting conversion to Alzheimer disease using standardized clinical information. , 2000, Archives of neurology.

[38]  B. Reed,et al.  Development of psychometrically matched English and Spanish language neuropsychological tests for older persons. , 2000, Neuropsychology.

[39]  S.-M. Kim,et al.  Glycation impairs high-density lipoprotein function , 2000, Diabetologia.

[40]  G. Siest,et al.  Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[41]  C. DeCarli,et al.  Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.

[42]  J. Haines,et al.  ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.

[43]  B. Horwitz,et al.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.

[44]  G. Ren,et al.  Optimized negative-staining electron microscopy for lipoprotein studies. , 2013, Biochimica et biophysica acta.